ライフサイエンスコーパス: cohort analysis

1 alysis to account for informative censoring (cohort analysis).

2 e interval, 0.11-0.79; P = 0.016 in combined cohorts analysis).

3 ogic outcomes were analyzed in retrospective cohort analysis.

4 ECMO using a propensity score-matched (1:1) cohort analysis.

5 ng kidney-only transplant in a retrospective cohort analysis.

6 along with 4032 subcohort members in a case-cohort analysis.

7 ransplant outcome in a uni- and multilateral cohort analysis.

8 to 2004 were included in this retrospective cohort analysis.

9 The study was a retrospective cohort analysis.

10 xaminations were included in a retrospective cohort analysis.

11 udy and deemed eligible for inclusionin this cohort analysis.

12 Poisson regression modeling in an age-period-cohort analysis.

13 traumatic brain injury in this observational cohort analysis.

14 ed and 407 unvaccinated women in the matched cohort analysis.

15 hild's third birthday, were included in this cohort analysis.

16 , VKA-ICH and NOAC-ICH in this observational cohort analysis.

17 pean patients, to conduct a population-level cohort analysis.

18 stigated albeit critical parameter for large-cohort analysis.

19 C or TMT by using a propensity score matched-cohort analysis.

20 Retrospective, longitudinal cohort analysis.

21 Sample to conduct a retrospective nationwide cohort analysis.

22 comparison women were identified for a case-cohort analysis.

23 We conducted a retrospective cohort analysis (2005-2011) of 695 deliveries involving

24 In an unmatched cohort analysis (3009 in the appendicectomy cohort and 1

25 ways: firstly replicating the trial reported cohort analysis acknowledging pairing of observations, b

26 Prospective cohort analysis among 4207 US men and women of a mean ag

27 ly, was 65% (61-68%) vs. 37% (31-43%) in the cohort analysis and 77% (67-84%) vs. 46% (25-61%) in the

28 However, in a cohort analysis and after adjustment for confounders, a

29 Propensity-matched cohort analysis and Cox proportional hazard model evalua

30 ease (CVD) were included in this prospective cohort analysis and followed for an average of 6.7 years

31 ectional retrospective study with age-period-cohort analysis and incidence projection modeling using

32 Retrospective cohort analysis and matched pairs analysis with historic

33 d albuminuria; in a propensity score-matched cohort analysis; and in sensitivity analyses.

34 This propensity score-matched retrospective cohort analysis assessed 2127 children and adolescents,

35 A retrospective cohort analysis at multiple tertiary academic centers wa

36 tional analysis (genomics) and retrospective cohort analysis (audiological measures) were conducted f

37 An age cohort analysis based on numbers of infected cattle, dos

38 This study involved a retrospective cohort analysis, based on growth-monitoring records span

39 In the cohort analysis, birth weight of <2,500 g was associated

40 In a second matched cohort analysis, children who were undervaccinated becau

41 Cohort analysis comparing patients with short-term (<5 y

42 ETTING, AND PARTICIPANTS: This retrospective cohort analysis, conducted from September 1, 2022, throu

43 Age-period-cohort analysis confirmed a significant increase in whit

44 AND PARTICIPANTS: In this single-institution cohort analysis, data were collected from patients with

45 nsistent with these observations, human GWAS cohort analysis demonstrated a significant association b

46 Age-period-cohort analysis demonstrated both cohort and period effe

47 The matched cohort analysis demonstrated that the BCRL group had sig

48 This large-cohort analysis demonstrates that although institutional

49 Estimates of rho from cohort analysis differ from those that consider the whol

50 Cohort analysis examined long-term MVPA trajectories acr

51 ING, AND PARTICIPANTS: This was a preplanned cohort analysis from the Multi-Arm Optimization of Strok

52 This exploratory cohort analysis grouped patients by baseline and most re

53 In this large prospective cohort analysis, higher serum retinol was associated wit

54 ING, AND PARTICIPANTS: This population-based cohort analysis identified adults (age >=16 years) who w

55 infants were eligible for this retrospective cohort analysis if enrolled at <18 months at 198 clinics

56 In this propensity score-matched cohort analysis in a US commercially insured population

57 ducted a single-center retrospective matched-cohort analysis in adult patients with Enterobacteriacea

58 We performed a retrospective cohort analysis in patients with high-risk AML who recei

59 We performed a secondary cohort analysis in the Enquiring About Tolerance (EAT) s

60 The authors conducted a prospective cohort analysis in the Women's Health Study (1992-2004),

61 13 of 61; 23%), we performed a retrospective cohort analysis in which patients with CF and PTLD were

62 ETTING, AND PARTICIPANTS: This retrospective cohort analysis included 105 785 patients with cutaneous

63 Our cohort analysis included 170 034 people: 112 936 in the

64 After propensity score matching, the main cohort analysis included 7496 patients, of whom 3748 had

65 ETTING, AND PARTICIPANTS: This retrospective cohort analysis included adult patients admitted to gene

66 ETTING, AND PARTICIPANTS: This retrospective cohort analysis included adult patients in the intensive

67 ETTING, AND PARTICIPANTS: This retrospective cohort analysis included patient records from the Nation

68 ETTING, AND PARTICIPANTS: This retrospective cohort analysis included patients diagnosed with RCC fro

69 ND PARTICIPANTS: This retrospective database cohort analysis included patients in 2 access programs a

70 ETTING, AND PARTICIPANTS: This retrospective cohort analysis included privately insured patients aged

71 Prospective, population-based cohort analysis including 21870 participants (20163 free

72 , AND PARTICIPANTS: This was a retrospective cohort analysis including patients 70 years or older at

73 challenges the theory that Frost discovered cohort analysis independently and gave it its name.

74 The aim of this retrospective cohort analysis is to derive objective two-dimensional e

75 ith somewhat lower cognitive scores in whole-cohort analysis (mean difference comparing offspring exp

76 This pooled cohort analysis merged individual data from 48286 partic

77 es the possibility of how genotype-phenotype cohort analysis might facilitate precision medicine in t

78 In another observational cohort analysis (n = 12,866), the percentage risk reduct

79 c women were sampled for inclusion in a case-cohort analysis (n=564 comprising the subcohort, n=479 e

80 RTICIPANTS: This population-based age-period-cohort analysis obtained OPC incidence data from the Sur

81 We undertook a population-based cohort analysis, obtaining data from every deceased-dono

82 A cohort analysis of 10 additional cancers included 236,50

83 A cohort analysis of 1193 patients having acute ischemic s

84 We carried out a cohort analysis of 121,422 children with anonymised link

85 adult patients, we conducted a retrospective cohort analysis of 1286 patients aged >/=18 years who un

86 A longitudinal, retrospective cohort analysis of 13,223 articles (5999 treatment, 7224

87 We undertook a retrospective cohort analysis of 137 kidney-pancreas transplant recipi

88 Retrospective cohort analysis of 15,015 patients with type 1 or 2 diab

89 We carried out a retrospective cohort analysis of 151,891 live-born singleton infants w

90 lity, and hospitalization in a retrospective cohort analysis of 1671 incident hemodialysis patients w

91 We conducted a retrospective cohort analysis of 18 patients who had anti-CASPR2 antib

92 Retrospective cohort analysis of 184875 patients with an infection-rel

93 We conducted a retrospective cohort analysis of 197 MDR tuberculosis patients treated

94 A prospective cohort analysis of 2 groups was performed.

95 NG, AND PARTICIPANTS: This was a prospective cohort analysis of 22 398 self-reported nonexercising ad

96 We performed a prospective cohort analysis of 220 white Caucasoid patients admitted

97 Conversely, a cohort analysis of 245 case intervals and 3,896 noncase

98 Cohort analysis of 26,638 stage I to III colorectal canc

99 DESIGN, SETTING, AND PATIENTS: Retrospective cohort analysis of 317,643 patients (n = 579,504 admissi

100 dence of type 2 diabetes (T2D).A prospective cohort analysis of 3349 individuals who were free of dia

101 TTING, AND PARTICIPANTS: In this prospective cohort analysis of 3412 older adults without diabetes fr

102 Retrospective cohort analysis of 3433 patients (aged 50-69 years) who

103 In the matched cohort analysis of 396,810 patients treated by IMG and U

104 Retrospective cohort analysis of 4253 patients aged 50 to 69 years who

105 om the United Kingdom were used to conduct a cohort analysis of 491,516 women.

106 DESIGN, SETTING, AND PATIENTS: Retrospective cohort analysis of 52,791 pediatric admissions to 54 U.S

107 Health Study (1980-2004); and a prospective cohort analysis of 69,693 participants without prior car

108 Prospective propensity-matched cohort analysis of 7 newly introduced cardiovascular dev

109 , SETTING, AND PARTICIPANTS: A retrospective cohort analysis of 701 patients with locally advanced NS

110 GN, SETTING, AND PARTICIPANTS: Retrospective cohort analysis of 748 090 adults aged 18 to 55 years in

111 The propensity scores matched cohort analysis of 786 patients without a wait time foun

112 We performed a retrospective cohort analysis of 88,201 blood cultures from 28,011 pat

113 We conducted a historical prospective cohort analysis of a 1.1-million-member, integrated, man

114 In this retrospective cohort analysis of a German longitudinal prescription da

115 In this retrospective cohort analysis of a German longitudinal prescription da

116 Society Adult Patient Database and a nested cohort analysis of a single center.

117 TING, AND PARTICIPANTS: This was a secondary cohort analysis of a single-arm clinical study including

118 We performed a retrospective cohort analysis of adult patients with an incident diagn

119 We performed a retrospective cohort analysis of adults hospitalized in the United Sta

120 We performed a retrospective cohort analysis of all consecutive adult patients who un

121 A retrospective nationwide cohort analysis of all renal transplantations in Norway

122 In this birth cohort analysis of all-cause dementia incidence in perso

123 r, but less precise, point estimate than the cohort analysis of brothers.

124 Descriptive study with age-period-cohort analysis of cancer registration data from the Nat

125 This was a retrospective cohort analysis of children treated on the Intergroup Rh

126 METHODS AND We performed a retrospective cohort analysis of claims data for Medicaid beneficiarie

127 Retrospective longitudinal cohort analysis of claims data from women 50 years or ol

128 Inception cohort analysis of data from 413 patients with early, un

129 A prospective cohort analysis of data from consecutive ICU patients ad

130 Retrospective cohort analysis of data from the FACS (follow-up after c

131 G, AND PARTICIPANTS: This is a retrospective cohort analysis of data from the National Health and Nut

132 We did a retrospective cohort analysis of data from the NLST, a randomised, mul

133 We did a retrospective cohort analysis of data from the Truven Health MarketSca

134 Retrospective observational cohort analysis of data gathered concurrently with patie

135 to find reliable effects, we present a multi-cohort analysis of dMRI metrics across 3047 individuals

136 of this study was to perform a case-matched cohort analysis of dual kidney transplantation (DKT) fro

137 A retrospective cohort analysis of elective operations from 2002 to 2008

138 We performed a retrospective cohort analysis of family physicians in Ontario, Canada,

139 Observational cohort analysis of geocoded longitudinal electronic heal

140 In a matched cohort analysis of hospitalized patients with severe COV

141 A case-cohort analysis of human immunodeficiency virus (HIV)-in

142 , AND PARTICIPANTS: This was a retrospective cohort analysis of longitudinal electronic health record

143 We conducted a population-based cohort analysis of medical records from 389 primary care

144 Retrospective cohort analysis of Medicare claims for 2002-2007, focusi

145 A retrospective longitudinal cohort analysis of national Medicaid claims data was con

146 GN, SETTING, AND PARTICIPANTS: Retrospective cohort analysis of neonates with HIE who underwent thera

147 An international multicentre cohort analysis of outpatients with bronchiectasis from

148 We conducted a retrospective cohort analysis of pairs of deceased donor kidney transp

149 We performed a case-cohort analysis of participants selected from the Reason

150 A single-center retrospective cohort analysis of patients 3-18 years screened for kera

151 We conducted a retrospective cohort analysis of patients from the SEATTLE II trial (P

152 We performed a retrospective cohort analysis of patients transplanted at our center w

153 To assess the impact of DOX, a contemporary cohort analysis of patients treated from 1975 to 1990 wa

154 To assess the impact of IF, a contemporary cohort analysis of patients treated from 1990 to 2003 wa

155 In this retrospective cohort analysis of patients treated with either nafcilli

156 A retrospective multicenter cohort analysis of patients who underwent pancreatoduode

157 rope, Asia, and Australia) and a multicenter cohort analysis of patients with advanced HCC treated wi

158 We performed a retrospective cohort analysis of PCIs from 18 facilities within one he

159 We performed a historical cohort analysis of pediatric CF patients in the United S

160 uate such steroid avoidance, a retrospective cohort analysis of pediatric kidney transplant recipient

161 In a retrospective cohort analysis of pediatric patients, we evaluated the

162 G, AND PARTICIPANTS: This is a retrospective cohort analysis of primary care practitioner (PCP) visit

163 ESIGN, SETTING, AND PARTICIPANTS: This was a cohort analysis of retrospectively collected longitudina

164 ucted two types of analysis: 1) a historical cohort analysis of singleton live births in New Jersey h

165 hma complicating pregnancy, using historical cohort analysis of singleton live deliveries in New Jers

166 In a cohort analysis of the ADVANCE (Action in Diabetes and V

167 We then performed a case-cohort analysis of the effects of hepatitis B viral fact

168 SIGN, SETTING, AND PARTICIPANTS: Exploratory cohort analysis of the Hypoglycaemia Prevention With Ora

169 A retrospective cohort analysis of the incidence of cancer in older adul

170 , SETTING, AND PARTICIPANTS: A retrospective cohort analysis of the largest multi-institutional elect

171 AND PARTICIPANTS: This study was a post hoc cohort analysis of the Preterm Erythropoietin Neuroprote

172 Secondary cohort analysis of the Promotion of Breastfeeding Interv

173 A retrospective cohort analysis of the Truven Health MarketScan Database

174 A retrospective cohort analysis of the Truven Health MarketScan Database

175 This was a retrospective cohort analysis of the U.S.

176 6), and a 1936 lecture on the age, time, and cohort analysis of tuberculosis mortality.

177 Survivor Study, we performed a retrospective cohort analysis of validated cases of congenital anomali

178 , SETTING, AND PARTICIPANTS: A retrospective cohort analysis of women aged 18 years or older diagnose

179 We conducted a retrospective cohort analysis on RR-TB patients treated with a standar

180 To validate associations, we performed a kin-cohort analysis on the 14 704 first-degree relatives of

181 tia after multiple adjustments in either the cohort analysis or a nested case-control design.

182 of baseline-matched subgroups concurred with cohort analysis (P = .009 for comparison of peginterfero

183 r analysis (p for trend = 0.009) than in the cohort analysis (p for trend = 0.18).

184 the CSGA cohort (P= .008), and in a combined cohort analysis (P= .003).

185 his prospective nonrandomized interventional cohort analysis performed at a tertiary referral center

186 DESIGN, SETTING, AND PARTICIPANTS: This cohort analysis pooled data from 3000 participants in 4

187 For the retrospective cohort analysis, raising vitamin D levels from <20 to >/

188 However, the Twins cohort analysis revealed a powerful role for common envi

189 As hypothesized, cohort analysis revealed a significantly higher damped n

190 Confirmatory HAE cohort analysis revealed significantly lower intact ITIH

191 Full cohort analysis revealed similar results.

192 ETTING, AND PARTICIPANTS: This retrospective cohort analysis reviewed the medical records for materna

193 Birth cohort analysis showed diminishing incidence rates throu

194 The birth-cohort analysis showed peak incidence rates in the 1880-

195 In the cohort analysis, smoking at baseline did not predict the

196 ic failure based on a Prentice weighted case-cohort analysis stratified by study.

197 ncer (OnCoRe) was a propensity-score matched cohort analysis study, that included patients of all age

198 For the cohort analysis, subject mother-infant dyads were identi

199 This single-center retrospective cohort analysis suggests that in hypersensitized kidney

200 Interpretation of this cohort analysis suggests that LET improves DFS and dista

201 Wade Hampton Frost developed methods for cohort analysis that formed the early basis for adjustme

202 es, as well as in a propensity score-matched cohort analysis that further assessed the impact of resi

203 We performed a retrospective cohort analysis that included 97 829 patients with paire

204 We conducted a prospective cohort analysis that involved 151 Kenyan sex workers.

205 The authors identified 1 large, matched cohort analysis that reported greater weight loss with s

206 In the cohort analysis, the number of prescriptions and the cum

207 In a crossover-cohort analysis, the odds of MI (OR 1.68 [95% CI 1.62-1.

208 In this large retrospective cohort analysis there was no evidence of any increased r

209 In each cohort analysis, there is substantial stability gained i

210 In the cohort analysis, there was no increased risk of multiple

211 In the cohort analysis, there were 2564 AMD subjects not on a v

212 We conducted a prospective cohort analysis to characterize the human immune respons

213 We did a retrospective cohort analysis to develop a continuous multivariable ri

214 We did a cohort analysis to estimate and compare incidence of VTE

215 We conducted a population-based cohort analysis to evaluate the incidence of chronic ren

216 e used both family-based and cross-sectional cohort analysis to test for interactions between CD14 ge

217 Thus, we performed a prospective (case-cohort) analysis to examine if persons who acquired type

218 The simulated full-cohort analysis triggered a sustained alert for Fidelis

219 In a matched cohort analysis, undervaccinated children had lower outp

220 ETTING, AND PARTICIPANTS: This retrospective cohort analysis used a 20% nationally representative sam

221 ETTING, AND PARTICIPANTS: This retrospective cohort analysis used a difference-in-differences study d

222 ETTING, AND PARTICIPANTS: This retrospective cohort analysis used data collected from January 1, 2007

223 ETTING, AND PARTICIPANTS: This retrospective cohort analysis used data from 2 large cohorts of young

224 ETTING, AND PARTICIPANTS: This retrospective cohort analysis used data from the GWTG-AFIB registry, a

225 ETTING, AND PARTICIPANTS: This retrospective cohort analysis used data from the satellite office of a

226 ETTING, AND PARTICIPANTS: This retrospective cohort analysis used data from the Symphony Health claim

227 DESIGN, SETTING, AND PARTICIPANTS: This cohort analysis used data from the Treatment of Preserve

228 ETTING, AND PARTICIPANTS: This retrospective cohort analysis used mortality data of young adults aged

229 DESIGN, SETTING, AND PARTICIPANTS: This cohort analysis used the large and still enrolling HeadS

230 This population-based retrospective cohort analysis used the National Cancer Database to sel

231 We conducted a retrospective cohort analysis using a national registry of US medical

232 In this retrospective cohort analysis using data from a large managed care dat

233 conducted a population-based, retrospective cohort analysis using data from all primiparous women wh

234 We performed a cohort analysis using data from the Cystic Fibrosis Foun

235 TS: A prospective, multicenter, longitudinal cohort analysis using HRQOL data from the PROST-QA and R

236 A retrospective cohort analysis using Medicare fee-for-service patients

237 A cohort analysis using the National Cancer Database compa

238 Observational intent-to-treat cohort analysis using the Veterans Affairs Clinical Case

239 A case-cohort analysis utilized 319 cases of selected causes of

240 We conducted a retrospective cohort analysis utilizing healthcare claims data from th

241 A cohort analysis was conducted among 6677 patients betwee

242 ETTING, AND PARTICIPANTS: This retrospective cohort analysis was conducted among a subset of patients

243 pective, population-based, season-stratified cohort analysis was conducted among children who were bo

244 A cohort analysis was conducted among participants in this

245 , SETTING, AND PARTICIPANTS: A retrospective cohort analysis was conducted from September 1, 2019, to

246 A retrospective cohort analysis was conducted of 199 adults who received

247 , SETTING, AND PARTICIPANTS: A retrospective cohort analysis was conducted of 566 patients with MF/SS

248 , SETTING, AND PARTICIPANTS: A retrospective cohort analysis was conducted of a 5% nationally random

249 A retrospective cohort analysis was conducted of data from January 1 to

250 A retrospective cohort analysis was conducted of patients aged 21 to 84

251 A retrospective cohort analysis was conducted of patients enrolled in th

252 A retrospective cohort analysis was conducted on Division 1 collegiate a

253 A retrospective cohort analysis was conducted using data collected betwe

254 An age-period-cohort analysis was conducted using data on 18,295 exami

255 , SETTING, AND PARTICIPANTS: A retrospective cohort analysis was conducted using electronic health re

256 CIPANTS: This retrospective population-level cohort analysis was conducted using the TriNetX Research

257 An observational cohort analysis was conducted within the Surveillance, P

258 A birth-cohort analysis was performed by calculating and compari

259 A matched-cohort analysis was performed for radiation-associated a

260 A retrospective cohort analysis was performed of confirmed mpox cases in

261 A retrospective cohort analysis was performed of randomly selected ACS p

262 A population-based cohort analysis was performed of women who gave birth in

263 A retrospective cohort analysis was performed on data from 124 patients,

264 A matched cohort analysis was performed to account for confounders

265 A multi-center cohort analysis was performed to characterize phenotype

266 Age-period-cohort analysis was performed to examine the trends.

267 A retrospective cohort analysis was performed using data collected from

268 A birth cohort analysis was performed using data from the Third

269 A historical cohort analysis was performed using histologic slides an

270 A retrospective longitudinal cohort analysis was performed using the MarketScan multi

271 A birth cohort analysis was performed, and survival rates over t

272 A cohort analysis was performed.

273 spective interrupted time-series and matched cohort analysis was performed.

274 The aim of this contemporary population-cohort analysis was to explore the effect of donor-recip

275 A case-cohort analysis was undertaken in a cohort of 56 837 wom

276 Propensity-matched cohort analysis was used in sensitivity analyses.

277 A supplemental cohort analysis was used to compare the risk of herpes z

278 Birth cohort analysis was used to isolate age and cohort effec

279 onmental Influences on Child Health Outcomes cohort; analysis was conducted from July to October 2023

280 For the international cohort analysis, we analysed clinical data from 705 pati

281 In a large retrospective cohort analysis, we analyzed data from the Swedish Regis

282 Based on a prospective cohort analysis, we demonstrated that magnesium intake i

283 For this national retrospective cohort analysis, we extracted UK National Health Service

284 In a cohort analysis, we further used repeated measures to es

285 In this cohort analysis, we included data from patients with CML

286 In a retrospective cohort analysis, we included data from patients with CML

287 In this longitudinal cohort analysis, we monitored a group of premature child

288 In a prospective cohort analysis, we studied 3483 people with CKD in the

289 population-based, self-matched, longitudinal cohort analysis, we studied 8815 adults from Ontario, Ca

290 In this retrospective cross-sectional cohort analysis, we used 2005-2009 Medicare data on bene

291 In this prospective population-based cohort analysis, we used data from the population-based

292 For this retrospective cohort analysis, we used observational data from 25 coun

293 Participants in our prospective cohort analysis were from a randomised placebo-controlle

294 A retrospective cohort analysis, which controlled for risk factors ident

295 Retrospective propensity-matched cohort analysis with accrual from September 1, 2012, to

296 ETTING, AND PARTICIPANTS: This retrospective cohort analysis with exact and propensity score-matched

297 A 1:1 propensity score matched cohort analysis with multivariate analysis of effects wa

298 A one-to-one propensity-matched matched cohort analysis with multivariate analysis of effects wa

299 NG, AND PARTICIPANTS: This was a prospective cohort analysis within the Vitamin D and Omega-3 Trial (

300 We did a retrospective cohort analysis, within the Childhood Cancer Survivor St